Cytokinetics Inc. buy Truist Financial Co.
Start price
08.04.24
/
50%
€68.00
Target price
08.04.25
€79.21
Performance (%)
-53.24%
End price
09.04.25
€31.80
Summary
This prediction ended on 09.04.25 with a price of €31.80. The BUY prediction by Truist_Financial_Co_ for Cytokinetics Inc. performed very badly with a performance of -53.24%. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 2.885% | 2.885% | 19.420% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $86.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.00
29.05.24
29.05.24
€64.57
29.05.25
29.05.25
-40.00%
30.05.25
30.05.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€76.00
28.12.23
28.12.23
€77.64
28.12.24
28.12.24
-41.05%
29.12.24
29.12.24